Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04152694 · ClinicalTrials.gov registry record · Phase 4
Ceftaroline Pharmacokinetics in Continuous Renal Replacement Therapy
A Phase 4 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT04152694: Completed Phase 4 study, sponsored by University of Maryland, Baltimore.
NCT04152694 is a Phase 4 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 4 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04152694, a Phase 4 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
Dosing of ceftaroline in patients with chronic kidney disease is defined, but there is no data on pharmacokinetics and pharmacodynamics of the drug in patients receiving continuous renal replacement therapy (CRRT). The purpose of this study is to determine pharmacokinetics and pharmacodynamics of ceftaroline in a critically ill patient population receiving CRRT, in order to define a dosing recommendation in this population.
Primary Outcome
Ceftaroline elimination half-life
Interventions
- OTHER Ceftaroline levels in CRRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-03-09 |
| Est. Completion | 2020-09-01 |
| Phase | Phase 4 |
What the finished NCT04152694 record still lists
NCT04152694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Ceftaroline levels in CRRT is the first listed.
NCT04152694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04152694 about?
NCT04152694 is a clinical study titled "Ceftaroline Pharmacokinetics in Continuous Renal Replacement Therapy". Dosing of ceftaroline in patients with chronic kidney disease is defined, but there is no data on pharmacokinetics and pharmacodynamics of the drug in patients receiving continuous renal replacement therapy (CRRT). The purpose of this study is to determine pharmacokinetics and pharmacodynamics of ce...
What is the current status of trial NCT04152694?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2018-03-09. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT04152694?
The interventions under investigation include: Ceftaroline levels in CRRT (OTHER).
Who is sponsoring clinical trial NCT04152694?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04152694's enrollment target sits among peer trials
4 1994th of 2000 higher than 6 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI